This reinforces the notion that the dominant immune response in VAT during early T2D pathogenesis is restricted to classical MHC class I-restricted CD8+ T cells, likely activated by adipose tissue-derived protein antigen. Here, CD8A is linked to type 2 diabetes mellitus.